Location History:
- San Jose, CA (US) (2022 - 2023)
- Emeryville, CA (US) (2023)
Company Filing History:
4 out of 48 
1 out of 560 
Years Active: 2022-2024
Title: The Innovative Contributions of Javier Morales
Introduction
Javier Morales is a prominent inventor based in San Jose, CA, known for his significant contributions to the field of cancer research. With a total of four patents to his name, he has made strides in developing therapeutic methods targeting specific cancer markers.
Latest Patents
Among his latest patents is a groundbreaking work on antibodies to mucin-16 (MUC16), which includes encoding polynucleotides and methods for treating MUC16-positive cancer. This patent provides compositions, methods, and uses involving anti-Mucin-16 agents that immunospecifically bind to an epitope of Mucin-16. Additionally, he has developed constructs targeting CD22, which describes antibodies and constructs that bind to the extracellular domain of CD22. These innovations are particularly relevant for the therapeutic treatment of diseases characterized by CD22 expression, such as B-cell lymphomas and leukemias.
Career Highlights
Javier has worked with notable organizations, including Eureka Therapeutics, Inc. and Memorial Sloan Kettering Cancer Center. His work in these institutions has allowed him to advance his research and contribute to significant developments in cancer treatment.
Collaborations
Some of his notable coworkers include Hong Liu and Yiyang Xu, who have collaborated with him on various projects aimed at enhancing cancer therapies.
Conclusion
Javier Morales continues to be a key figure in the field of cancer research, with his innovative patents paving the way for new treatment methods. His work exemplifies the impact of dedicated inventors in advancing medical science.